1 / 82

NCLEX RN Preparation Program

NCLEX RN Preparation Program. Respiratory Disorders Module 5, Part 3 of 3. Emphysema + Chronic Bronchitis = COPD Chronic Obstructive Pulmonary Disease. Chronic Airflow Limitation.

hiroko
Download Presentation

NCLEX RN Preparation Program

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. NCLEX RN Preparation Program Respiratory Disorders Module 5, Part 3 of 3

  2. Emphysema + Chronic Bronchitis = COPD Chronic Obstructive Pulmonary Disease Chronic Airflow Limitation Photo Source: National Heart, Lung and Blood Institute (NHLBI http://www.nhlbi.nih.gov/health/dci/Diseases/Copd/Copd_WhatIs.html

  3. Emphysema • Loss of lung elasticity • Hyperinflation • Air trapped in lungs • Alveoli over-stretched  bullae

  4. Chronic Bronchitis • Recurrent inflammation  Vasodilation, Congestion, Edema, Spasm • Excessive thick mucus blocks air flow • Hypoxemia, CO2 retained

  5. Causes of COPD • Smoking • Alpha1-Antitrypsin Deficiency • Air pollution • Secondary smoke Photo Source: National Cancer Society, http://visualsonline.cancer.gov/details.cfm?imageid=1997 and http://visualsonline.cancer.gov/details.cfm?imageid=2740

  6. Signs of COPD • General • Breathing • Sputum • Sounds • Skin • Finger tips

  7. Assess • LOC • Airway status and breathing • Pulses • RR, depth • BP, Heart Rate • SpO 2 level on room air • Color, temperature & capillary refill

  8. Is this an emergency? • Dyspnea scale 0-10 • Oxygen saturation < 90% • Peak flow < 300 ml

  9. Diagnostic Tests • Arterial Blood Gases • Oxygen Saturation • Chest x-ray • Labs • Pulmonary Function Tests (PFTs)

  10. Goal: Patent Airway • Position • Secretions • Mucolytics • Expectoration • Hydration • Humidifier

  11. Teach Effective Breathing • Diaphragm • Pursed-lips • Controlled cough • Orthopneic position http://emphysemafoundation.org/pulhthex.jsp

  12. Bronchospasm • Bronchodilators • Cholinergic antagonists • Theophyllins

  13. Inflammation Infection • Inhaled steroids • Systemic steroids • Prevent pneumonia • Influenza vaccination yearly • Pneumovax q 5 years

  14. Conserve Energy • Schedule activities • Don’t rush • Supplemental oxygen • Avoid arm raises

  15. Mealtime Strategies • Rest • 4-6 small meals • Bronchodilator ac • Easy chewing • Supplements • Avoid gas-producing foods

  16. Stepped Therapy • Combivent (ipratropium + albuterol) • Add beta2 agonist (Albuterol) • Add theophyllin • Add Prednisone

  17. Control Anxiety = Dyspnea • Develop a plan • Develop support network • Join support group

  18. Complementary/Alternatives • Ask about non-prescribed methods used • Teach relaxation techniques

  19. Pneumonia Photo Source: Centers for Disease Control, Wikimedia Commons, http://commons.wikimedia.org/wiki/Image:Pneumonia_x_ray.jpg

  20. Categories • Viral • Fungal • Bacterial • Aspiration Photo Source: USDS, http://www.ars.usda.gov/is/graphics/photos/sep01/k9606-20.htm]

  21. Classification • Causative agent (Streptococcus pneumoniae) • Anatomic location of the infection (lobar pneumonia) • By where it was acquired (community vs. hospital/nosocomial)

  22. Major Organisms • Community-acquired: • Streptococcus pneumoniae (gram +) • Staphylococcus aureus (gram +) • Nosocomial: • Staphylococcus aureus (gram +) • MRSA

  23. Who is at greatest risk? Photo Source: National Camcer Society, http://visualsonline.cancer.gov/details.cfm?imageid=1994 and http://visualsonline.cancer.gov/details.cfm?imageid=2193

  24. Community Prevention Pneumovax Wash hands Don’t smoke Wear mask: dusty, moldy areas Avoid crowds Eat healthy diet Exercise

  25. Nosocomial Prevention • Prevent aspiration - How? • Prevent cross-contamination • Vaccinate inpatients • Education • Mouth care??

  26. Signs & Symptoms • Fever, chills • Dyspnea, RR, shallow breathing • Coughing, crackles, wheezing • Pleuritic pain • Anorexia • Hypoxemia • Sputum: purulent, blood-tinged, rusty

  27. Diagnosis • Sputum C&S • Leukocytosis • ABG’s • Blood C&S • Chest x-ray • Oxygen saturation

  28. Goal: Improve Gas Exchange • Oxygen • Antibiotics • Rest • Incentive spirometry • Raise head of bed • No smoking

  29. Goal: Clear Airway • Enhance cough strength • Bronchodilators • Rest • Mucolytics • Corticosteroids

  30. Goal: Control Pain and Fever • Pain • Fever control • Adequate volume

  31. Pulmonary Tuberculosis Photo Source: Centers for Disease Control (CDC) / Wikimedia Commons, http://commons.wikimedia.org/wiki/Image:Mantoux_tuberculin_skin_test.jpg and http://commons.wikimedia.org/wiki/Image:TB_CXR.jpg

  32. Tuberculosis: What is it? • Mycobacterium tuberculosis causes inflammation in upper lungs • Bacillus colonies form a lesion (tubercle) • When the colonies die, they cause necrosis & scar tissue (consumption of tissue) Photo Source: Centers for Disease Control (CDC) / Wikimedia Commons, http://commons.wikimedia.org/wiki/Image:Mycobacterium_tuberculosis_8438_lores.jpg

  33. How do I know I have it? • Cough that will not go away • Feeling tired all the time • Weight loss • Loss of appetite • Fever • Coughing up blood • Night sweats

  34. Diagnosis • Initial Screening – skin test • Positive if >10mm induration • Chest x-ray  • Sputum for AFB

  35. Skin Testing • Mantoux • 0.1 ml PPD • 48-72 hours • induration • False-positive • False-negative Photo Source: Centers for Disease Control (CDC) / Wikimedia Commons, http://commons.wikimedia.org/wiki/Image:Mantoux_tuberculin_skin_test.jpg

  36. Chest X-ray • To confirm positive PPD • When PPD cannot be done • Cavitation • Caseation

  37. Sputum Testing • First morning specimen • 3 days • Acid-fast Bacilli • Tb C & S Photo Source: Centers for Disease Control (CDC) / Wikimedia Commons, http://commons.wikimedia.org/wiki/Image:TB_Culture.jpg

  38. How is it treated? • Initial Therapy may include: • Isoniazid (INH) • Rifampin • Pyrazinamide (PZA) • Ethambutol or Streptomycin • After two months: • Isoniazid • Rifampin

  39. Isoniazid • Precautions: • Take on empty stomach, avoid antacids • LFTs if liver disease • Warnings: • Increases Dilantin & Tegretol levels

  40. Rifampin • Precautions • Body secretions turn orange • May ruin contact lenses • Warnings • Reduces contraceptive, methadone effect • May interact with anti-retrovirals

  41. Rifapentine • Precautions • Probably discolors body secretions • Warnings • Decreased potency diabetes meds, barbs, antibiotics, contraceptives

  42. Ethambutol • Precautions • Decreased visual acuity • Decreased red-green color discrimination • Warnings • Optic toxicity is dose related • Increased toxicity with renal insufficiency

  43. Pyrazinamide • Precautions • Hepatotoxicity • Nausea/vomiting • Polyarthralgias • Hyper-uricemia • Transient rash • Photo-sensitive dermatitis

  44. Hospitalization • Isolate all patients with active pulmonary TB in negative-pressure rooms with high-volume air replacement and circulation • Continue isolation until combined drug treatment has been administered for 2 weeks, and three consecutive sputum smears have tested negative.

  45. Transplant Recipients • Immune suppressed • Donor organ with latent TB • Reactivate pt’s latent infection • Diagnosis difficult • Decreased PPD reaction

  46. HIV positive • Increased risk: Why? • Interactions with protease inhibitors • Decreased CD4 cell count  anergy (impaired or absent ability to react to common antigens administered through skin) • PPD testing early in HIV infection • Use control to rule out anergy • ?? INH prophylaxis

  47. Drug Toxicity • Hx of liver disease • Consuming alcohol daily • Baseline + repeat LFTs • Watch! • Dark urine • Light stools • Fatigue

  48. Drug Resistance • Multi-drug resistant TB (MDRTB) • Second-line drugs • Increased time of treatment

  49. Non-compliance • Failure of treatment • Resistant bacilli • Intermittent dosing? • Arrest the patient?

  50. Patient/Family Teaching • Prevention • Phone contact • Test entire family • Use precautions • Follow-up sputum cultures • Diet

More Related